Lv51
958 积分 2023-11-23 加入
Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T‐cell therapy: A CIBMTR analysis
2小时前
待确认
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
1个月前
已完结
Derivation and validation of a novel score for early prediction of severe CRS after CAR‐T therapy in haematological malignancy patients: A multi‐centre study
1个月前
已完结
Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-cell Lymphoma
1个月前
已完结
Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
4个月前
已完结
[Research Progress on the Influence of Blood Tumor Microen-vironment on the Efficacy and the Adverse Reactions of CAR-T Cell Immunotherapy--Review]
4个月前
已关闭
[Research Progress on the Influence of Blood Tumor Microen-vironment on the Efficacy and the Adverse Reactions of CAR-T Cell Immunotherapy--Review]
4个月前
已关闭
CAR T-cell-associated neurotoxicity: A comprehensive review
4个月前
已完结
From the IASLC Tobacco Control Committee
4个月前
已完结
Novel strategies to manage CAR-T cell toxicity
5个月前
已完结
皖公网安备34019202002308
